Skip to content

Tempus AI, Inc. TEM Diagnostics — Cost of Goods Sold

Similar metrics at other companies

Revvity logo
RVTYDiagnostics — Segment Cost of Revenue
$156.75M+16.0%
TEC
TECHDiagnostics And Spatial Biology — Cost of Goods Sold
$38.65M+3.9%
Labcorp Holdings logo
LHDiagnostics — Supplies Expense
$613.5M+4.6%
Natera, Inc. logo
NTRAProduct revenues — Cost of revenues
$245.2M+32.8%
GE HealthCare Technologies logo
GEHCPDx — Cost of Sales
$406M+38.1%
Bio-Rad Laboratories logo
BIO.BClinical Diagnostics — Cost of goods sold

Other financials

Income statement

See full
Revenue$348.1M+36.1%
Operating income-$84.7M-23.3%
Net income-$125.9M-85.1%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$525.9M+243%
Total debt$85.4M+49.8%
Total equity$416.4M+27.7%
Total assets$2.1B+38.4%

Cash flow

See full
Operating cash flow-$73.3M+30.6%
CapEx$8.2M+295%
Free cash flow-$81.5M+24.3%

Valuation

See full
Market cap$9.13B-2.7%
Enterprise value$8.69B-6.9%
P/S6.7×-5.0×

Profitability

See full
Operating margin-19.7%-8.6pp
Net margin-22.2%-9.5pp
FCF margin-54.5%

Returns & leverage

See full
Return on equity-81.6%
Debt / equity0.2×0.0×
Current ratio3.3×+1.6×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s diagnostics — cost of goods sold.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tempus AI, Inc.'s diagnostics — cost of goods sold?
Tempus AI, Inc. (TEM) reported diagnostics — cost of goods sold of $100.96M in Q1 2026.
How has Tempus AI, Inc.'s diagnostics — cost of goods sold changed year-over-year?
Tempus AI, Inc.'s diagnostics — cost of goods sold increased by 19.1% year-over-year, from $84.78M to $100.96M.
What does diagnostics — cost of goods sold mean?
The direct costs associated with producing and delivering diagnostic tests and services.
How do you interpret diagnostics — cost of goods sold?
An increase relative to revenue suggests margin compression or rising operational inefficiencies, while a decrease relative to revenue indicates improved economies of scale or operational leverage.
How does diagnostics — cost of goods sold compare across companies?
Comparable to 'Cost of Revenue' or 'Direct Cost of Services' reported by companies in the clinical laboratory, diagnostics, or precision medicine sectors.